Pathology Diagnosis of Pancreatic Neuroendocrine Tumors
Overview
Affiliations
Histopathology of pancreatic neuroendocrine tumors (PNETs) typically displays characteristic features. However, pathologists may encounter histological variants that may resemble other pancreatic tumors. Immunohistochemistry is a powerful tool in confirming neuroendocrine differentiation and differentiating PNETs with other pancreatic neoplasms. Histopathological features could be associated with inherited syndromes. Once the pathology diagnosis of neuroendocrine tumor was made, an accurate grading based on World Health Organization (WHO) classification is required. This review will focus on histology variants, immunohistochemistry and WHO classification of PNET.
Lai J, Lin C, Ho K, Chang C BMC Gastroenterol. 2024; 24(1):415.
PMID: 39563255 PMC: 11577853. DOI: 10.1186/s12876-024-03517-z.
The expanding role of endoscopic ultrasound elastography.
Dhar J, Samanta J Clin J Gastroenterol. 2022; 15(5):841-858.
PMID: 35789474 DOI: 10.1007/s12328-022-01662-0.
CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.
Gu D, Hu Y, Ding H, Wei J, Chen K, Liu H Eur Radiol. 2019; 29(12):6880-6890.
PMID: 31227882 DOI: 10.1007/s00330-019-06176-x.
Endoscopic ultrasound elastography for solid pancreatic lesions.
Chantarojanasiri T, Kongkam P World J Gastrointest Endosc. 2017; 9(10):506-513.
PMID: 29085561 PMC: 5648993. DOI: 10.4253/wjge.v9.i10.506.
Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor.
Tanigawa M, Nakayama M, Taira T, Hattori S, Mihara Y, Kondo R Med Mol Morphol. 2017; 51(1):32-40.
PMID: 28849340 DOI: 10.1007/s00795-017-0167-6.